Subscribe
WRAIR’s Military HIV Research Program headed the RV144 “Thai study,” the first-ever – and only to-date – clinical trial to demonstrate an HIV vaccine regimen was safe and modestly effective in preventing HIV infection. The RV144 trial represented a massive undertaking for the Army and serves as a model of international and interagency collaboration.
The trial involved more than 16,000 adult volunteers and a large network of partners who still collaborate with WRAIR today, including the Thai Ministry of Public Health, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, and Sanofi Pasteur.
In Fall 2009 the Army announced that the investigational prime-boost vaccine regimen lowered the rate of HIV infection by 31.2 percent. These results, though modest, gave the global community hope that a vaccine to prevent HIV infection is possible at a time when such an achievement seemed elusive.
| Date Taken: | 11.26.2019 |
| Date Posted: | 12.06.2019 15:34 |
| Category: | Video Productions |
| Video ID: | 726545 |
| VIRIN: | 192611-A-A1902-001 |
| Filename: | DOD_107498036 |
| Length: | 00:06:00 |
| Location: | US |
| Downloads: | 3 |
| High-Res. Downloads: | 3 |
Asset contains copyrighted material
Portions of the asset are subject to restrictions under U.S. copyright law and are not licensed for distribution. Please contact us for details.
